Loading...

Subscriptions

Purchase a Subscription

Independent Editorial

Ben Harrington
Tags
Terms and Conditions

Betaville Intelligence subscriptions

Terms and Conditions

Tagged: 'GlaxoSmithKline'

GlaxoSmithKline pays almost $1 billion for 35Pharma Inc - Betaville.co.uk

GlaxoSmithKline pays almost $1 billion for 35Pharma Inc

Wednesday, 25 February 2026 8:46 am

There were more signs of a rekindling of dealmaking activity in the biopharmaceutical industry this morning.

GlaxoSmithKline

GlaxoSmithKline snaps up Rapt Therapeutics for $2.2 billion

Tuesday, 20 January 2026 10:23 am

Just when little old Betaville thought the dealmaking frenzy in US-listed biotechnology stocks was slowing down GlaxoSmithKline pops up with a $1.9 billion takeover of Rapt Therapeutics, a developer therapies for patients living with food allergies and inflammatory diseases.

GlaxoSmithKline

Rapt Therapeutics

The Times airs £300 billion AstraZeneca GlaxoSmithKline merger rumour

Monday, 12 January 2026 4:09 pm

Chums at The Times dedicate a double page spread in today's business section to a piece about a quite scintillating deal rumour: a possible £300 billion tie up of AstraZeneca and GlaxoSmithKline.

GlaxoSmithKline

GlaxoSmithKline snaps up Boston Pharmaceutical's asset for up to $2 billion

Wednesday, 14 May 2025 7:36 am

Getting deals done in biopharmaceutical industry has been tough over the last few months but today FTSE 100-listed giant GlaxoSmithKline announced the $2 billion acquisition of Boston Pharmaceutical's lead asset, efimosfermin alfa.

GlaxoSmithKline

Boston Pharmaceutical

TG Therapeutics may be a takeover target for Roche, tweets ex Times business hack Dom Walsh

Wednesday, 13 November 2024 4:46 pm

Dominic "Dom" Walsh is at it again.

GlaxoSmithKline

GlaxoSmithKline splashes out $1.4 billion on Aiolos Bio, Inc

Tuesday, 09 January 2024 7:49 amAnother day, another biopharmaucetical takeover.

GlaxoSmithKline

Deals, Deals, Deals ... in a bear market - Part 45

Tuesday, 18 April 2023 8:20 amNew deals are being announced on a daily basis at the moment.

GlaxoSmithKline

Canaccord Genuity's Quest bullish about takeover deals ... - Part 4

Wednesday, 11 January 2023 2:14 pmIt's that time of the year when scribblers at Canaccord Genuity's Quest release a note with their UK M&A takeover tips - all 94 of them.

Canaccord Genuity

Marks & Spencer

Reckitt Benckiser

GlaxoSmithKline

Betaville Intelligence

RARE ALERT: GlaxoSmithKline said to ... - Part 5

Tuesday, 22 March 2022 4:24 pmThe European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.

GlaxoSmithKline

Exclusive to Betaville Intelligence subscribers

RARE ALERT: GlaxoSmithKline said to ... - Part 4

Monday, 07 March 2022 3:00 pmA European-based investor group has launched a campaign to persuade the board of Aurinia Pharmaceuticals Inc to carry out a strategic review of the US-listed drug developer.

GlaxoSmithKline

GlaxoSmithKline said to be eyeing £1 billion plus takeover bid for Theravance Biopharma, reports The Times

Friday, 11 February 2022 8:21 amHas GlaxoSmithKline given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?

GlaxoSmithKline

Aurinia Pharmaceuticals

Theranvance Biopharma

Unilever may be a target for activist such as Nelson Peltz, reports FT - Part 3

Sunday, 23 January 2022 12:37 pmThe Unilever might be a target for Nelson Peltz theory was first aired last summer but now it appears to be have become fact.

Financial Times

GlaxoSmithKline

Unilever bids £50 billion for GlaxoSmithKline's consumer arm, reveals The Sunday Times - Part 3

Saturday, 22 January 2022 8:43 amDominic O'Connell, a former boss during my time jobbing on The Sunday Times busines desk, appears to be suggesting something similar to Sky News's Ian "Kingy" King earlier in the week.

GlaxoSmithKline

The Sunday Times

Unilever bids £50 billion for GlaxoSmithKline's consumer arm, reveals The Sunday Times - Part 2

Monday, 17 January 2022 9:57 pmWell, it looks like Ian "Kingy" King is first out of the traps to highlight something little old Betaville has been ruminating on with an old City contact over a few glasses down the pub this evening.

GlaxoSmithKline

Unilever bids £50 billion for GlaxoSmithKline's consumer arm, reveals The Sunday Times

Saturday, 15 January 2022 9:59 amThere is a big deal story breaking this Saturday morning from, er, The Sunday Times.

GlaxoSmithKline

The Sunday Times

Exclusive to Betaville Intelligence subscribers

RARE ALERT: GlaxoSmithKline said to ... - Part 3

Thursday, 09 December 2021 6:06 pmAurinia Pharmaceuticals, the US-listed biotechnology company developing treatments for rare diseases, is rumoured to be "close to picking" a preferred bidder as its strategic review draws to a close.

GlaxoSmithKline

Betaville Intelligence

RARE ALERT: GlaxoSmithKline said to ...

Thursday, 28 October 2021 3:04 pmFTSE 100-listed GlaxoSmithKline, Switzerland-based Roche and Japan's Otsuka Pharmaceutical are all rumoured to be the large pharmaceutical companies involved in the strategic review being carried by Aurinia Pharmaceuticals, the US-listed rare disease drug developer.

GlaxoSmithKline

Sunday review: GlaxoSmithKline, Elliott Management and Caxton Associates

Sunday, 16 May 2021 5:10 pmChums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management.

GlaxoSmithKline

The Sunday Times

Elliott Management

Caxton Associates

UK dealmaking in the doldrums because of Brexit - perhaps not...

Wednesday, 19 December 2018 1:19 pmTypical!

GlaxoSmithKline

The Greenhill conundrum...

Tuesday, 27 March 2018 7:08 pm

GlaxoSmithKline

1
2
20 / page